These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 4751258)

  • 1. Phase I study of chromomycin A (NSC-58514).
    Kovach JS; Moertel CG; Ahmann DL; Hahn RG; Schutt AJ; Donadio JV
    Cancer Chemother Rep; 1973; 57(3):341-7. PubMed ID: 4751258
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II study of chromomycin A3 (NSC-58514) in advanced colorectal carcinoma.
    Moertel CG; Schutt AJ; Hahn RG; Marciniak TA; Reitemeier RJ
    Cancer Chemother Rep; 1975; 59(3):577-9. PubMed ID: 1203884
    [No Abstract]   [Full Text] [Related]  

  • 3. Preclinical toxicologic evaluation of chromomycin A3 (NSC-58 514) in mice, dogs and monkeys.
    Fleischman RW; Schaeppi U; Heyman IA; Phelan RS; Rosenkrantz H; Ilievski V
    Toxicol Appl Pharmacol; 1974 Feb; 27(2):259-70. PubMed ID: 4212258
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytosine arabinoside (NSC 63878) toxicity and antitumor acitivity in human solid tumors.
    Davis HL; Rochlin DB; Weiss AJ; Wilson WL; Andrews NC; Madden R; Sedransk N
    Oncology; 1974; 29(3):190-200. PubMed ID: 4412696
    [No Abstract]   [Full Text] [Related]  

  • 5. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with gastrointestinal carcinoma.
    Moertel CG; Reitemeier RJ; Hahn RG; Schutt AJ
    Cancer Chemother Rep; 1970 Dec; 54(6):471-3. PubMed ID: 4946016
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II study of camptothecin (NSC-100880) in the treatment of advanced gastrointestinal cancer.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Chemother Rep; 1972 Feb; 56(1):95-101. PubMed ID: 5030811
    [No Abstract]   [Full Text] [Related]  

  • 7. Chromomycin A3 for advanced breast cancer: a Southwest Oncology Group study.
    Samal B; Jones S; Brownlee RW; Morrison F; Hoogstraten B; Caoili E; Baker L
    Cancer Treat Rep; 1978 Jan; 62(1):19-22. PubMed ID: 342093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic and toxic effects of mithramycin during tumor therapy.
    Kennedy BJ
    Am J Med; 1970 Oct; 49(4):494-503. PubMed ID: 4320120
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination chemotherapy in gastrointestinal cancer.
    Reitemeier RJ; Moertel CG; Hahn RG
    Cancer Res; 1970 May; 30(5):1425-8. PubMed ID: 4246651
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase I-II evaluation of weekly mitomycin-C (NSC-26980) for patients with metastatic GI and breast malignancies.
    Hum GJ; Bogdon DL; Bateman JR
    Oncology; 1974; 30(3):236-43. PubMed ID: 4459738
    [No Abstract]   [Full Text] [Related]  

  • 11. [Phase-II-study with vindesine (desacetyl-vinblastine-amide-sulfate) in advanced malignant diseases].
    Goldhirsch A; Beer M; Sonntag RW; Tschopp L; Cavalli F; Ryssel HJ; Brunner KW
    Schweiz Med Wochenschr; 1980 Jul; 110(27-28):1063-7. PubMed ID: 7423151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I alternate-day dose study of chromomycin A3.
    Reynolds RD; Fisher JI; Jensen PA; Pajak TF; Bateman JR
    Cancer Treat Rep; 1976 Sep; 60(9):1251-5. PubMed ID: 1035132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Hodgkin's disease and other cancers with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
    Marsh JC; DeConti RC; Hubbard SP
    Cancer Chemother Rep; 1971 Dec; 55(5):599-606. PubMed ID: 4334161
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical experience with mitomycin C (NSC-26980).
    Whittington RM; Close HP
    Cancer Chemother Rep; 1970 Jun; 54(3):195-8. PubMed ID: 4334088
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of cancer with weekly intravenous 5-fluorouracil. Study by the Western Cooperative Cancer Chemotherapy Group (WCCCG).
    Jacobs EM; Reeves WJ; Wood DA; Pugh R; Braunwald J; Bateman JR
    Cancer; 1971 Jun; 27(6):1302-5. PubMed ID: 5088208
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination chemotherapy for solid tumors using 5-fluorouracil, chromomycin-A, and prednisolone.
    Saito T; Wakui A; Yokoyama M; Himori T; Takahashi H; Kudo T; Takahashi K
    Gan; 1977 Aug; 68(4):375-87. PubMed ID: 616414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of strepozotocin (NSC-85998) in the treatment of advanced gastrointestinal cancer.
    Moertel CG; Reitemeier RJ; Schutt AJ; Hahn RG
    Cancer Chemother Rep; 1971 Jun; 55(3):303-7. PubMed ID: 5115851
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of 37 surgical cancers with associated or isolated chemotherapy].
    Montezin J
    Bull Mem Soc Chir Paris; 1971; 61(6):352-68. PubMed ID: 5152093
    [No Abstract]   [Full Text] [Related]  

  • 19. 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in the treatment of malignant tumors other than melanoma.
    Kingra GS; Comis R; Olson KB; Horton J
    Cancer Chemother Rep; 1971 Jun; 55(3):281-3. PubMed ID: 5115849
    [No Abstract]   [Full Text] [Related]  

  • 20. [Limits and possibilities of cytostatic therapy with massive doses of cyclophosphamide].
    Chiarelli G; Garutti GP; Rambaldi P
    Arcisp S Anna Ferrara; 1967; 20(3):385-400. PubMed ID: 5606860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.